Melatonin: Signaling mechanisms of a pleiotropic agent

BioFactors

Volumn 35, Issue 2, 2009, Pages 183-192

  Hardeland, Rüdigger ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chronobiotic; Melatonin binding sites; MT1 MT2; ROR RZR

Indexed keywords

CALCIUM ION; CALMODULIN; CALRETICULIN; CELL NUCLEUS RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; HETERODIMER; HOMODIMER; ION CHANNEL; MELATONIN; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; POTASSIUM ION; PROTEIN KINASE B; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RETINOIC ACID RECEPTOR; SCAFFOLD PROTEIN; THROMBOPLASTIN; VOLTAGE GATED CALCIUM CHANNEL; CELL SURFACE RECEPTOR;

BINDING SITE; CELL MEMBRANE; CIRCADIAN RHYTHM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAMMAL; MITOCHONDRION; NONHUMAN; PINEAL BODY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; ANIMAL; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

MAMMALIA;

ANIMALS; BINDING SITES; HUMANS; MELATONIN; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 67649236122     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.23     Document Type: Review

References (92)

1. Reiter, R. J. (1993) The melatonin rhythm: both a clock and a calendar. Experientia 49, 654-664.
2. Arendt, J., and Skene, D. J. (2005) Melatonin as a chronobiotic. Sleep Med. Rev. 9, 25-39.
3. Pandi-Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., and Hardeland, R. (2006) Melatonin - nature's most versatile biological signal? FEBS J. 273, 2813-2838.
4. Hardeland, R. (2008) Melatonin, hormone of darkness and more - occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. 65, 2001-2018.
5. Tan, D.-X., Manchester, L. C., Hardeland, R., Lopez-Burillo, S., Mayo, J. C., Sainz, R. M., and Reiter, R. J. (2003) Melatonin - a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J. Pineal Res. 34, 75-78.
6. Hardeland, R., and Poeggeler, B. (2008) Melatonin beyond its classical functions. Open Physiol. J. 1, 1-23.
7. Tricoire, H., Locatelli, A., Chemineau, P., and Malpaux, B. (2002) Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 143, 84-90.
8. Tricoire, H., Malpaux, B., and Moøller, M. (2003) Cellular lining of the sheep pineal recess studied by light-, transmission-, and scanning electron microscopy: morphologic indications for a direct secretion of melatonin from the pineal gland to the cerebrospinal fluid. J. Comp. Neurol. 456, 39-47.
9. Bubenik, G. A. (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 47, 2336-2348.
10. Hardeland, R., and Pandi-Perumal, S. R. (2005) Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr. Metab. (Lond.) 2, article no. 22.
11. Tan, D.-X., Manchester, L. C., Reiter, R. J., Qi, W., Hanes, M. A., and Farley, N. J. (1999) High physiological levels of melatonin in the bile of mammals. Life Sci. 65, 2523-2529.
12. Hardeland, R., and Fuhrberg, B. (1996) Ubiquitous melatonin - Presence and effects in unicells, plants and animals. Trends Comp. Biochem. Physiol. 2, 25-45.
13. Hardeland, R., and Poeggeler, B. (2003) Non-vertebrate melatonin. J. Pineal Res. 34, 233-241.
14. Hardeland, R., Pandi-Perumal, S. R., and Poeggeler, B. (2007) Melatonin in plants - focus on a vertebrate night hormone with cytoprotective properties. Funct. Plant Sci. Biotechnol. 1, 32-45.
15. Hernández-Ruiz, J., Cano, A., and Arnao, M. B. (2004) Melatonin: a growth-stimulating compound present in lupin tissues. Planta 220, 140-144.
16. Hernández-Ruiz, J., Cano, A., and Arnao, M. B. (2005) Melatonin acts as a growth-stimulating compound in some monocot species. J. Pineal Res. 39, 137-142.
17. Tan, D.-X., Chen, L.-D., Poeggeler, B., Manchester, L. C., and Reiter, R. J. (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1, 57-60.
18. Reiter, R. J., Poeggeler, B., Tan, D.-X., Chen, L.-D., Manchester, L. C., and Guerrero, J. M. (1993) Antioxidant capacity of melatonin: A novel action not requiring a receptor. Neuroendocrinol. Lett. 15, 103-116.
19. Hardeland, R. (2005) Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27, 119-130.
20. 1 and MT2 melatonin receptors in mammals. Endocrine 27, 101-110.
21. Klante, G., Secci, K., Masson-Pévet, M., Pévet, P., Vivien-Roels, B., Steinlechner, S., and Wollnik, F. (1999) Interstrain differences in activity pattern, pineal function, and SCN melatonin receptor density of rats. Am. J. Physiol. 276, R1078-R1086.
22. Schuster, C., Gauer, F., Guerrero, H., Lakhdar-Ghazal, N., Pévet, P., and Masson-Pévet, M. (2000) Photic regulation of mt1 melatonin receptors in the Siberian hamster pars tuberalis and suprachiasmatic nuclei: involvement of the circadian clock and intergeniculate leaflet. J. Neuroendocrinol. 12, 207-216.
23. 1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J. Comp. Neurol. 499, 897-910.
24. Korf, H. W., and von Gall, C. (2006) Mice, melatonin and the circadian system. Mol. Cell. Endocrinol. 252, 57-68.
25. Ross, A. W., and Morgan, P. J. (2002) The pars tuberalis as a target of the central clock. Cell Tissue Res. 309, 163-171.
26. Hardeland, R., Coto-Montes, A., and Poeggeler, B. (2003) Circadian rhythms, oxidative stress and antioxidative defense mechanisms. Chronobiol. Int. 20, 921-962.
27. Reppert, S. M., Weaver, D. R., and Ebisawa, T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13, 1177-1185.
28. Reppert, S. M., Godson, C., Mahle, C. D., Weaver, D. R., Slaugenhaupt, S. A., and Gusella, J. F. (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA 92, 8734-8738.
29. Jin, X., von Gall, C., Pieschl, R. L., Gribkoff, V. K., Stehle, J. H., Reppert, S. M., and Weaver, D. R. (2003) Targeted disruption of the mouse Mel1b melatonin receptor. Mol. Cell. Biol. 23, 1054-1060.
30. Jockers, R., Petit, L., Lacroix, I., de Coppet, P., Barrett, P., Morgan, P. J., Guardiola, B., Delagrange, P., Marullo, S., and Strosberg, A. D. (1997) Novel isoforms of Mel1c melatonin receptors modulating intracellular cyclic guanosine 30,50-monophosphate levels. Mol. Endocrinol. 11, 1070-1081.
31. Song, Y., Chan, C. W., Brown, G. M., Pang, S. F., and Silverman, M. (1997) Studies of the renal action of melatonin: evidence that the effects are mediated by 37 kDa receptors of the Mel1a subtype localized primarily to the basolateral membrane of the proximal tubule. FASEB J. 11, 93-100.
32. Rivera-Bermùdez, M. A., Masana, M. I., Brown, G. M., Earnest, D. J., and Dubocovich, M. L. (2004) Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors. Brain Res. 1002, 21-27.
33. 1 and MT2 melatonin receptors are involved in internalization processes. J. Pineal Res. 45, 212-218.
34. Pandi-Perumal, S. R., Srinivasan, V., Poeggeler, B., Hardeland, R., and Cardinali, D. P. (2007) Drug insight: the use of melatonergic agonists for the treatment of insomnia - focus on ramelteon. Nat. Clin. Pract. Neurol. 3, 221-228.
35. 1 melatonin receptor, but leads to receptor down-regulation. J. Pineal Res. 43, 255-262.
36. Gerdin, M. J., Masana, M. I., Rivera-Bermùdez, M. A., Hudson, R. L., Earnest, D. J., Gillette, M. U., and Dubocovich, M. L. (2004) Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J. 18, 1646-1656.
37. 1 and hMT2 melatonin receptors. J. Pharmacol. Exp. Ther. 304, 931-939.
38. 1/MT2 receptor agonist. Neuropharmacology 48, 301-310.
39. von Gall, C., Stehle, J. H., and Weaver, D. R. (2002) Mammalian melatonin receptors: molecular biology and signal tranduction. Cell Tissue Res. 309, 151-162.
40. Hunt, A. E., Al-Ghoul, W. M., Gillette, M. U., and Dubocovich, M. L. (2001) Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am. J. Physiol. 280, C110-C118.
41. Liu, C., Weaver, D. R., Jin, X., Shearman, L. P., Pieschl, R. L., Gribkoff, V. K., and Reppert, S. M. (1997) Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19, 91-102.
42. 1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters. Mol. Endocrinol. 10, 1478-1487.
43. Godson, C., and Reppert, S. M. (1997) The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138, 397-404.
44. Dubocovich, M. L., Rivera-Bermudez, M. A., Gerdin, M. J., and Masana, M. I. (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 8, d1093-d1108.
45. von Gall, C., and Weaver, D. R. (2008) Loss of responsiveness to melatonin in the aging mouse suprachiasmatic nucleus. Neurobiol. Aging 29, 464-470.
46. 1 melatonin receptor mRNA tissular localization by PCR amplification. Neuroendocrinol. Lett. 24, 33-38.
47. q/11 proteins. Mol. Endocrinol. 13, 2025-2038.
48. Pandi-Perumal, S. R., Trakht, I., Srinivasan, V., Spence, D. W., Maestroni, G. J. M., Zisapel, N., and Cardinali, D. P. (2008) Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 85, 335-353.
49. McArthur, A. J., Hunt, E. A., and Gillette, M. U. (1997) Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: Activation of protein kinase C at dusk and dawn. Endocrinology 138, 627-634.
50. Birnbaumer, L. (2007) Expansion of the signal transduction by G proteins the second 15 years or so: From 3 to 16 a subunits to bc dimers. Biochim. Biophys. Acta 1768, 772-793.
51. + channel activity. Mol. Endocrinol. 17, 2103-2115.
52. Geary, G. G., Krause, D. N., and Duckles, S. P. (1997) Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am. J. Physiol. 273, H1530-H1536.
53. + channels and endothelial factors. Br. J. Pharmacol. 123, 1533-1540.
54. Viswanathan, M., Laitinen, J. T., and Saavedra, J. M. (1990) Expression of melatonin receptors in arteries involved in thermoregulation. Proc. Natl. Acad. Sci. USA 87, 6200-6203.
55. Nelson, C. S., Marino, J. L., and Allen, C. N. (1996) Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport 7, 717-720.
56. Nelson, C. S., Ikeda, M., Gompf, H. S., Robinson, M. L., Fuchs, N. K., Yoshioka, T., Neve, K. A., and Allen, C. N. (2001) Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124. Mol. Endocrinol. 15, 1306-1317.
57. Roka, F., Brydon, L., Waldhoer, M., Strosberg, A. D., Freissmuth, M., Jockers, R., and Nanoff, C. (1999) Tight association of the human Mel1amelatonin receptor and Gi: precoupling and constitutive activity. Mol. Pharmacol. 56, 1014-1024.
58. 2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and insensitive G proteins. Cell. Signal. 14, 249-257.
59. 2 and Xenopus Mel1c receptors. J. Neurochem. 80, 736-745.
60. 1 melatonin receptor intenalization underlies melatonin-induced morphologic changes in Chinese hamster overy cells and these processes are dependent on Gi proteins, MEK1/2 and microtubule modulation. J. Pineal Res. 44, 288-298.
61. Maggio, R., Novi, F., Scarselli, M., and Corsini, G. U. (2005) The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J. 272, 2939-2946.
62. Cui, P., Yu, M., Luo, Z., Dai, M., Han, J., Xiu, R., and Yang, Z. (2008) Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J. Pineal Res. 44, 107-114.
63. Rimler, A., Jockers, R., Lupowitz, Z., and Zisapel, N. (2007) Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion. J. Mol. Neurosci. 31, 1-12.
64. Stumpf, I., Mühlbauer, E., and Peschke, E. (2008) Involvement of the cGMP pathway in mediating the insulin-inhibitory of melatonin in pancreatic β-cells. J. Pineal Res. 45, 318-327.
65. Tamura, E. K., Silva, C. L., and Markus, R. P. (2006) Melatonin inhibits nitric oxide production in vitro. J. Pineal Res. 41, 267-274.
66. Guillaume, J. L., Daulat, A. M., Maurice, P., Levoye, A., Migaud, M., Brydon, L., Malpaux, B., Borg-Capra, C., and Jockers, R. (2008) The PDZ protein mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor. J. Biol. Chem. 283, 16762-16771.
67. 2 homodimers. Mol. Pharmacol. 66, 312-321. (Pubitemid 38989488)
68. Park, P. S.-H., Lodowski, D. T., and Palczewski, K. (2008) Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. Annu. Rev. Pharmacol. Toxicol. 48, 107-141.
69. 1 melatonin receptor function through heterodimerization. EMBO J. 25, 3012-3023.
70. Dufourny, L., Levasseur, A., Migaud, M., Callebaut, I., Pontarotti, P., Malpaux, B., and Monget, P. (2008) GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals. BMC Evol. Biol. 8, article no. 105.
71. Barrett, P., Ivanova, E., Graham, E. S., Ross, A. W., Wilson, D., Plé , H., Mercer, J. G., Ebling, F. J., Schuhler, S., Dupré, S. M., Loudon, A., and Morgan, P. J. (2006) Photoperiodic regulation of cellular retinoic acidbinding protein 1, GPR50 and nestin in tanycytes of the third ventricle ependymal layer of the Siberian hamster. J. Endocrinol. 191, 687-698.
72. 3 as the quinone reductase 2. J. Biol. Chem. 275, 31311-31317.
73. 1 binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochem. Pharmacol. 71, 74-78.
74. Wiesenberg, I., Missbach, M., Kahlen, J. P., Schräder, M., and Carlberg, C. (1995) Transcriptional activation of the nuclear receptor RZRa by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23, 327-333.
75. Carlberg, C. (2000) Gene regulation by melatonin. Ann. NY Acad. Sci. 917, 387-396.
76. Tomás-Zapico, C., and Coto-Montes, A. (2005) A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 39, 99-104.
77. Schräder, M., Danielsson, C., Wiesenberg, I., and Carlberg, C. (1996) Identification of natural monomeric response elements of the nuclear receptor RZR/ROR. They also bind COUP-TF homodimers. J. Biol. Chem. 271, 19732-19736.
78. Agez, L., Laurent, V., Pévet, P., Masson-Pévet, M., and Gauer, F. (2007) Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 144, 522-530.
79. Greiner, E. F., Kirfel, J., Greschik, H., U.Dörflinger, Becker, P., Mercep, A., and Schüle, R. (1996) Functional analysis of retinoid Z receptor beta, a brain-specific nuclear orphan receptor. Proc. Natl. Acad. Sci. USA 93, 10105-10110.
80. Steinhilber, D., Brungs, M., Werz, O., Wiesenberg, I., Danielsson, C., Kahlen, J. P., Nayeri, S., Schräder, M., and Carlberg, C. (1995) The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270, 7037-7040.
81. Kim, E. J., Yoo, Y. G., Yang, W. K., Lim, Y. S., Na, T. Y., Lee, I. K., and Lee, M. O. (2008) Transcriptional activation of HIF-1 by RORa and its role in hypoxia signaling. Arterioscler. Thromb. Vasc. Biol. 28, 1796-1802.
82. 3H-melatonin to calmodulin. Life Sci. 53, 201-207.
83. Benítez-King, G., and Antón-Tay, F. (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 49, 635-641.
84. Turjanski, A. G., Estrin, D. A., Rosenstein, R. E., Mccormick, J. E., Martin, S. R., Pastore, A., Biekofsky, R. R., and Martorana, V. (2007) The interaction between melatonin to calmodulin: a NMR and molecular dynamics study. In Melatonin - From Molecules to Therapy. (Pandi-Perumal, S. R., and Cardinali, D. P., eds.). pp. 47-68, Nova Science, New York.
85. Landau, M., Zisapel, N. (2007) The low affinity binding of melatonin to calmodulin: use of computational methods to explain its physiological relevance. In Melatonin - From Molecules to Therapy. (Pandi-Perumal, S. R., and Cardinali, D. P., eds.). pp. 69-79, Nova Science, New York.
86. 2+/calmodulin- dependent kinase II activity by melatonin. Biochim. Biophys. Acta 1290, 191-196.
87. León, J., Macías, M., Escames, G., Camacho, E., Khaldy, H., Martín, M., Espinosa, A., Gallo, M. A., and Acuña-Castroviejo, D. (2000) Structurerelated inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol. Pharmacol. 58, 967-975.
88. Macías, M., Escames, G., Leon, J., Coto, A., Sbihi, Y., Osuna, A., and Acuña-Castroviejo, D. (2003) Calreticulin - melatonin. An unexpected relationship. Eur. J. Biochem. 270, 832-840.
89. Andrabi, S. A., Sayeed, I., Siemen, D., Wolf, G., and Horn, T. F. (2004) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J. 18, 869-871.
90. Hardeland, R., Poeggeler, B., and Pappolla, M. A. (2008) New vistas on mitochondrial electron flux rates and aging. Cell, Comment; Available at: http://www.cell.com/content/article/comments?uid1/4PIIS0092867408000627
91. Lardone, P. J., Carrillo-Vico, A., Molinero, P., Rubio, A., and Guerrero, J. M. (2009) A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production. Cell. Mol. Life Sci. 66, 516-525.
92. Hardeland, R., and Poeggeler, B. (2007) Actions of melatonin, its structural and functional analogs in the central nervous system and the significance of metabolism. Cent. Nerv. Syst. Agents Med. Chem. 7, 289-303.